CASI Pharmaceuticals
CASI
#9771
Rank
NZ$50.33 M
Marketcap
$3.25
Share price
0.46%
Change (1 day)
-14.25%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$64.22 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$28.53 Million. a decrease over its 2023 earnings that were of -NZ$44.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$63.79 Million44.35%
2023 -NZ$44.19 Million-29.55%
2022 -NZ$62.72 Million4.43%
2021 -NZ$60.06 Million-24.56%
2020 -NZ$79.61 Million4.74%
2019 -NZ$76.01 Million65.13%
2018 -NZ$46.03 Million155.07%
2017 -NZ$18.05 Million13.93%
2016 -NZ$15.84 Million31.18%
2015 -NZ$12.08 Million-72.5%
2014 -NZ$43.91 Million356.62%
2013 -NZ$9.62 Million-60.55%
2012 -NZ$24.38 Million218.41%
2011 -NZ$7.66 Million0.74%
2010 -NZ$7.6 Million-32.54%
2009 -NZ$11.27 Million-66.98%
2008 -NZ$34.11 Million-14.22%
2007 -NZ$39.77 Million7.04%
2006 -NZ$37.15 Million27.95%
2005 -NZ$29.04 Million4.51%
2004 -NZ$27.78 Million-15.84%
2003 -NZ$33.01 Million-55.29%
2002 -NZ$73.83 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$84.98 Million31.56%
1999 -NZ$64.6 Million145.56%
1998 -NZ$26.31 Million76.4%
1997 -NZ$14.92 Million36.92%
1996 -NZ$10.9 Million